Bayer Sells Plasma Unit to US Investors
230256
Bayer AG has agreed to sell its plasma products business to US investors Cerberus Capital Management and Ampersand Ventures for US$590 million (euro445 million) in cash and stock, the German drug and chemical company said Monday.
285978
German chemical and drug maker Bayer AG said Thursday that it will sell its HC Starck division to private-equity firms Advent International and The Carlyle Group for more than $900 million in cash.
385384
BERLIN  - Shareholders of German drug maker Bayer AG approved plans Wednesday to spin off chemicals and polymers business Lanxess, clearing the way for its listing on the stock market early next year.
518261
Medical device maker Boston Scientific Corp. said Tuesday that it made an equity investment in Reva Medical Inc. and secured an exclusive option to purchase the privately held San Diego firm, which is developing
501320
German chemicals and pharmaceuticals giant Bayer said that it has agreed to sell its metals subsidiary HC Starck to private equity firms Advent and Carlyle for about 1.2 billion euros (1.6 billion dollars) in total.
606574
Bayer AG, the German drug and chemical company, has agreed to sell its plasma products business for &#36;590 million in cash and stock to the private U.S. investment groups Cerberus Capital Management and Ampersand Ventures.
59757
Clayton, Dubilier &amp; Rice Inc. is leading a 2.6 billion-euro ($3.45 billion) buyout of an electrical- equipment supplier from France&#39;s Pinault-Printemps-Redoute SA, the New York-based firm&#39;s third European acquisition this year.
217896
FRANKFURT Bayer said Monday that it had formed a partnership with Schering-Plough to market some of its biggest drugs in the United States.
551896
Shareholders of German drug maker Bayer AG approved plans Wednesday to spin off chemicals and polymers business Lanxess, clearing the way for its listing on the stock market early next year.
181334
The firm scraps an alliance with Moxell to bring Motorola-branded plasma TVs, LCD TVs and monitors to North America and China.
245551
Schering-Plough (SGP:NYSE - news - research) Monday announced a broad marketing agreement with Germany&#39;s Bayer (BAY:NYSE - news - research) that both companies said will lead to a more efficient use of their marketing and sales strengths.
142333
German chemicals and pharmaceuticals giant Bayer said it had acquired the marketing rights for GlaxoSmithKline's erectile dysfunction treatment Levitra in a number of countries outside the US for 208 million euros (272 million dollars).
717798
German drugs and chemicals group  Merck KGaA sold its worldwide electronic chemicals business to  BASF for 270 million euros ($352 million), the two companies  said on Friday.
624076
The Dutch retail giant Ahold said Tuesday it had finalised the sale of its US division US Foodservice to private equity funds Clayton, Dubilier, Rice and Kohlberg Kravis Roberts for 7.1 billion dollars (5.2 billion euros).
119312
Akzo Nobel said on Monday it was selling its pharmaceuticals unit Organon BioSciences to Schering-Plough for 11 billion euros ($14.5 billion), dropping plans to float it in a public share offer.
749953
A group of investors led by Boston Red Sox owner John Henry has completed a deal to buy a 50 percent stake in the Roush Racing NASCAR team, a person familiar with the negotiations said Friday.
341615
Johnson &amp; Johnson&#39;s$25.4bn purchase of Guidant, a medical device maker, will give the big US medical group a range of fast-growing products that manage patients&#39; heart rhythms, a move that will shake up the US medical device industry.